CAR-TCR Summit Europe
February 27-29, 2024 – London, UK
Cell therapy continues to transform oncology with advances across in vivo engineering and novel armouring enhancements. This year has also seen the translation of cell therapies’ curative potential into the autoimmune space to capitalize on their targeting abilities. And innovation is showing no signs of slowing for those working in CAR-T and TCR drug development, as the mission to engineer a disease-free world remains front of mind.
Providing access to cutting-edge advances across pre-clinical platforms, clinical advances, and streamlined manufacturing, the 7th CAR-TCR Summit Europe is your must-attend forum to stay at the forefront of cell therapy innovations.
300+ industry experts will unite in London this February 27-29 to brainstorm enhancing target discovery, optimizing durability of response and identifying biomarkers to support recruitment; through to automating production and accelerating analytical processes to reduce operational costs and turnaround times.
With leading stakeholders like J&J, Immatics, Umoja Biopharma, Mnemo Therapeutics, and Celyad confirmed to attend, can you afford to miss out?
MabDesign members benefit from 10% discount upon registration : Ask Us for the code